Loading...
CareRx Corporation
CRRX.TO•TSX
HealthcareMedical - Care Facilities
CA$2.83
CA$-0.02(-0.70%)
CareRx Corporation (CRRX.TO) Financial Performance & Statements
Review CareRx Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-1.09%
↓ 1.09%
Operating Income Growth
-3.10%
↓ 3.10%
Net Income Growth
16.73%
↑ 16.73%
Operating Cash Flow Growth
38.78%
↑ 38.78%
Operating Margin
1.30%
↑ 1.30%
Gross Margin
29.53%
↑ 29.53%
Net Profit Margin
-1.03%
↓ 1.03%
ROE
-4.54%
↓ 4.54%
ROIC
2.93%
↑ 2.93%
CareRx Corporation (CRRX.TO) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for CareRx Corporation stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $92.18M | $92.84M | $91.97M | $89.73M |
| Cost of Revenue | $64.84M | $65.80M | $64.70M | $68.13M |
| Gross Profit | $27.34M | $27.03M | $27.27M | $21.60M |
| Gross Profit Ratio | $0.30 | $0.29 | $0.30 | $0.24 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $9.84M | $8.05M | $20.12M | $19.45M |
| Operating Expenses | $27.42M | $25.16M | $20.12M | $19.45M |
| Total Costs & Expenses | $92.26M | $90.96M | $90.99M | $87.58M |
| Interest Income | $29000.00 | $32000.00 | $1000.00 | $38000.00 |
| Interest Expense | $2.14M | $2.17M | $2.34M | $2.42M |
| Depreciation & Amortization | $4.78M | $4.77M | $4.82M | $4.82M |
| EBITDA | $4.94M | $6.58M | $5.79M | $6.76M |
| EBITDA Ratio | $0.05 | $0.07 | $0.06 | $0.08 |
| Operating Income | -$81000.00 | $1.87M | $980000.00 | $2.15M |
| Operating Income Ratio | -$0.001 | $0.02 | $0.01 | $0.02 |
| Other Income/Expenses (Net) | -$2.13M | -$2.23M | -$2.36M | -$2.27M |
| Income Before Tax | -$2.21M | -$360000.00 | -$1.38M | -$517000.00 |
| Income Before Tax Ratio | -$0.02 | -$0.004 | -$0.01 | -$0.006 |
| Income Tax Expense | $32000.00 | $0.00 | $0.00 | $4.77M |
| Net Income | -$2.25M | -$360000.00 | -$1.38M | -$517000.00 |
| Net Income Ratio | -$0.02 | -$0.004 | -$0.01 | -$0.006 |
| EPS | -$0.04 | -$0.006 | -$0.02 | -$0.009 |
| Diluted EPS | -$0.04 | -$0.006 | -$0.02 | -$0.009 |
| Weighted Avg Shares Outstanding | $62.15M | $60.09M | $60.13M | $59.86M |
| Weighted Avg Shares Outstanding (Diluted) | $62.15M | $60.09M | $60.13M | $59.86M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan